Related Experiment Video
Updated: Apr 16, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Phenotype-genotype correlations for clinical variants caused by CYLD mutations
Nikoletta Nagy1, Katalin Farkas2, Lajos Kemény3
1Department of Medical Genetics, University of Szeged, Szeged, Hungary; Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary; Dermatological Research Group of the Hungarian Academy of Sciences, University of Szeged, Szeged, Hungary.
Brooke-Spiegler syndrome (BSS) and related disorders are caused by mutations in the CYLD gene. This study reviews CYLD mutations and their correlation with clinical symptoms, aiding diagnosis and understanding of these rare skin conditions.
Area of Science:
- Genetics
- Dermatology
- Molecular Biology
Background:
- Brooke-Spiegler syndrome (BSS) is an autosomal dominant disorder characterized by skin appendageal neoplasms.
- Mutations in the cylindromatosis (CYLD) gene cause BSS, familial cylindromatosis (FC), and multiple familial trichoepithelioma type 1 (MFT1).
- The CYLD gene encodes a deubiquitinase enzyme, and 95 disease-causing mutations have been identified previously.
Purpose of the Study:
- To summarize CYLD gene mutations found in Hungarian patients.
- To review previously published CYLD gene mutations.
- To analyze genotype-phenotype correlations in BSS, FC, and MFT1.
Main Methods:
- Literature review of published CYLD gene mutations.
- Analysis of mutations identified in Hungarian patients.
- Correlation analysis between CYLD genotypes and clinical phenotypes.
Main Results:
- The majority of CYLD mutations are frameshift (48%), nonsense (27%), missense (12%), and splice-site (11%).
- Most mutations are located in exons 9-20 of the CYLD gene.
- Significant genotype-phenotype correlations were observed for BSS, FC, and MFT1.
Conclusions:
- Understanding genotype-phenotype correlations is crucial for diagnosing rare monogenic skin diseases like BSS.
- Characterizing these correlations can advance the understanding of disease mechanisms.
- This knowledge may contribute to developing future therapeutic strategies for these conditions.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Principles of Pharmacogenetics: Types of Genetic Variants
Genetic Lingo
Pharmacogenomics: Identification of New Drug Targets
Pleiotropy

